| Authors: |
Skowronski DM; Immunization Programs and Vaccine Preventable Diseases Service, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Ranadheera C; Influenza, Respiratory Virus and Coronavirus Section, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Kaweski SE; Immunization Programs and Vaccine Preventable Diseases Service, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Sabaiduc S; Immunization Programs and Vaccine Preventable Diseases Service, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Separovic L; Immunization Programs and Vaccine Preventable Diseases Service, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Makowski G; Influenza, Respiratory Virus and Coronavirus Section, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Ung J; Influenza, Respiratory Virus and Coronavirus Section, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Reyes RC; Medical Scientific Department, LifeLabs, Burnaby, British Columbia, Canada., Henry B; Office of the Provincial Health Officer, Ministry of Health, Victoria, British Columbia, Canada., Albert A; Epidemiology and Intelligence Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Clemens F; Epidemiology and Intelligence Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Kobasa D; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Bastien N; Influenza, Respiratory Virus and Coronavirus Section, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada. |
